BENZTROPINE

Course overview

BENZTROPINE IS FDA APPROVED AS ADJUNCTIVE THERAPY FOR ALL FORMS OF PARKINSONISM. IT IS ALSO USED FOR DRUG-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND THE PREVENTION OF DYSTONIC REACTIONS AS WELL AS ACUTE TREATMENT OF DYSTONIC REACTIONS. THIS ACTIVITY EXAMINES THE INDICATIONS, MECHANISM OF ACTION, DOSING, ADVERSE EVENT PROFILE, AND OTHER FACTORS SO MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM CAN MAKE INFORMED DECISIONS REGARDING THE USE OF THIS DRUG IN PATIENT CARE.